|
gptkbp:instanceOf
|
gptkb:vaccine
|
|
gptkbp:administeredBy
|
children
healthcare professionals
|
|
gptkbp:administeredDuring
|
polio eradication campaigns
|
|
gptkbp:alternativeTo
|
gptkb:inactivated_polio_vaccine_(IPV)
|
|
gptkbp:broadcastOn
|
multiple doses
|
|
gptkbp:contains
|
live attenuated poliovirus
|
|
gptkbp:countryOfOrigin
|
gptkb:Soviet_Union
|
|
gptkbp:developedBy
|
gptkb:Albert_Sabin
|
|
gptkbp:doseForm
|
liquid drops
|
|
gptkbp:effect
|
high
|
|
gptkbp:globalPresence
|
widespread
|
|
gptkbp:introducedIn
|
1961
|
|
gptkbp:notRecommendedFor
|
immunocompromised individuals
|
|
gptkbp:riskFactor
|
rare reversion to neurovirulence
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
vaccine-associated paralytic poliomyelitis (VAPP)
|
|
gptkbp:storage
|
refrigerated
|
|
gptkbp:target
|
poliovirus infection
|
|
gptkbp:type
|
bivalent
monovalent
trivalent
|
|
gptkbp:usedFor
|
prevention of poliomyelitis
|
|
gptkbp:WHORecommended
|
yes
|
|
gptkbp:WHOStatus
|
gptkb:World_Health_Organization's_List_of_Essential_Medicines
|
|
gptkbp:bfsParent
|
gptkb:Polio
gptkb:Inactivated_polio_vaccine_(IPV)
|
|
gptkbp:bfsLayer
|
8
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
oral polio vaccine (OPV)
|